Janis Gorton

Houston

3704 Travis Street
Houston, Texas 77002
Phone: (713) 529-5622
Fax: (713) 529-3785

Background

Janis Gorton began her career at Berg & Androphy in 2008. She works primarily on qui tam litigation with an emphasis on fraud pertaining to government health care programs. She is currently pursuing multiple qui tam suits, many of which are still under seal, on subjects ranging from fraudulent pharmaceutical price inflation, kickbacks associated with Medicare and Medicaid programs, Stark violations, billing for medically unnecessary services and services not provided, provision of worthless services, and off-label marketing.

Education

  • J.D., University of Texas School of Law
  • B.S., University of Texas at Austin, cum laude

Publications

Federal Criminal White Collar Appellate Update, The Appellate Advocate, State Bar of Texas Appellate Section Update, June 2011

Associations and Honors

  • Houston Bar Association
  • Houston Young Lawyers Association
  • Association of Women Attorneys

Representative Matters:

  • With Joel Androphy, won a settlement with Health Services Management, Inc. and Huntsville Health Care Center. The case, filed on behalf of the United States and the State of Texas, alleged that the defendants billed Medicare and Texas Medicaid for services, which were not rendered or were so deficient and substandard that they harmed nursing home patients and were essentially worthless services. The settlement netted the Government and client more than $4.5 million. In addition to the monetary settlement, the parties’ agreement requires HSM to enter into a Corporate Integrity Agreement with the Office of the Inspector General.
  • With Joel Androphy, represented a whistleblower in a retaliation claim, resulting in a favorable settlement after mediation. 
  • With Joel Androphy, won a settlement with Mallinckrodt Pharmaceuticals, Tyco International, Ltd., Tyco Healthcare Group LP, and Covidien, who agreed to pay nearly $1 million to settle civil allegations that they caused state Medicaid programs to pay inflated rates for prescription medications by submitting inflated pricing information to Medicaid agencies and to third-party compendia publications used by state agencies to set Medicaid reimbursement amounts.

Admissions

  • Texas
  • U.S. Court of Appeals, Fifth Circuit
  • U.S. District Court, Southern District of Texas
  • U.S. District Court, District of New Mexico
  • U.S. District Court, Western District of Michigan